Keith S. Hoek

6.2k citations

40 papers · 4.4k indexed · 1 hit paper · h-index 29

Co-authors: Colin R. Goding Reinhard Dummer Natalie C. Schlegel Ossia M. Eichhoff Silvio Hemmi Ross Smith Udo Döbbeling Nikita Kobert
Topics: Melanoma and MAPK Pathways (14 papers)Cell Adhesion Molecules Research (9 papers)Cutaneous Melanoma Detection and Management (6 papers)
Cited by: Cell Biology Immunology and Allergy Oncology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: Switzerland United States Australia

In The Last Decade

Keith S. Hoek

40 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States

2008 523 citations Keith S. Hoek, Ossia M. Eichhoff et al. Cancer Research profile →

Peers

Countries citing papers authored by Keith S. Hoek

Since Specialization

Citations

This map shows the geographic impact of Keith S. Hoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith S. Hoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith S. Hoek more than expected).

Fields of papers citing papers by Keith S. Hoek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith S. Hoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith S. Hoek. The network helps show where Keith S. Hoek may publish in the future.

Co-authorship network of co-authors of Keith S. Hoek

This figure shows the co-authorship network connecting the top 25 collaborators of Keith S. Hoek. A scholar is included among the top collaborators of Keith S. Hoek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith S. Hoek. Keith S. Hoek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching 2013 ·Journal of Investigative Dermatology ·Daniel Widmer,Keith S. Hoek,Phil F. Cheng,Ossia M. Eichhoff,Thomas Biedermann,Marieke I.G. Raaijmakers,Silvio Hemmi,Reinhard Dummer,Mitchell P. Levesque	110
2	Systematic classification of melanoma cells by phenotype‐specific gene expression mapping 2012 ·Pigment Cell & Melanoma Research ·Daniel Widmer,Phil F. Cheng,Ossia M. Eichhoff,Benedetta Belloni,Marie Zipser,Natalie C. Schlegel,Delphine Javelaud,Alain Mauviel,Reinhard Dummer,Keith S. Hoek	126
3	Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching 2011 ·Pigment Cell & Melanoma Research ·Ossia M. Eichhoff,Ashani T. Weeraratna,Marie Zipser,Laurence Denat,Daniel Widmer,Mai Xu,Lydia Kriegl,Thomas Kirchner,Lionel Larue,Reinhard Dummer,Keith S. Hoek	72
4	GLI2 and M‐MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells 2011 ·Pigment Cell & Melanoma Research ·Delphine Javelaud,Vasileia Ismini Alexaki,(unknown),Keith S. Hoek,Sylviane Dennler,Léon C.L.T. van Kempen,Corine Bertolotto,Robert Ballotti,Simon Saule,Véronique Delmas,Alain Mauviel	63
5	A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status 2010 ·Pigment Cell & Melanoma Research ·Marie Zipser,Ossia M. Eichhoff,Daniel Widmer,Natalie C. Schlegel,(unknown),Darrin D. Stuart,Weihua Liu,Humphrey Gardner,Paul D. Smith,Paolo Nucíforo,Reinhard Dummer,Keith S. Hoek	54
6	The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report 2010 ·Melanoma Research ·Ossia M. Eichhoff,Marie Zipser,Mai Xu,Ashani T. Weeraratna,Daniela Mihic‐Probst,Reinhard Dummer,Keith S. Hoek	35
7	Exploring melanoma’s massively parallel universe 2010 ·Pigment Cell & Melanoma Research ·Keith S. Hoek	1
8	Wnt5A Activates the Calpain-Mediated Cleavage of Filamin A 2009 ·Journal of Investigative Dermatology ·Michael P. O’Connell,Jennifer L. Fiori,(unknown),Fred E. Indig,Amanda D. French,Tura C. Camilli,Brittany P. Frank,(unknown),Keith S. Hoek,(unknown),E. George Elias,Dennis D. Taub,Michel Bernier,Ashani T. Weeraratna	58
9	Id2 suppression of p15 counters TGF‐β‐mediated growth inhibition of melanoma cells 2009 ·Pigment Cell & Melanoma Research ·Natalie C. Schlegel,Ossia M. Eichhoff,Silvio Hemmi,Sabine Werner,Reinhard Dummer,Keith S. Hoek	17
10	CT-X antigen expression in human breast cancer 2009 ·Proceedings of the National Academy of Sciences ·Anita Grigoriadis,Otávia L. Caballero,Keith S. Hoek,Leonard Da Silva,Yao‐Tseng Chen,Sandra J. Shin,Achim A. Jungbluth,Lance D. Miller,David Clouston,Jonathan Cebon,Lloyd J. Old,Sunil R. Lakhani,Andrew J.G. Simpson,Alan Nevill	93
11	‘Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma’ 2009 ·Oncogene ·José L. Orgaz,(unknown),Keith S. Hoek,Asunción Fernández‐Barral,(unknown),Óscar Aguilera,Elisabeth A. Seftor,António Bernad,José Luis Rodríguez‐Peralto,Mary J.C. Hendrix,Olga V. Volpert,Benilde Jiménez	60
12	In vivo Switching of Human Melanoma Cells between Proliferative and Invasive Statesbreakdown → 2008 ·Cancer Research ·Keith S. Hoek,Ossia M. Eichhoff,Natalie C. Schlegel,Udo Döbbeling,Nikita Kobert,Leo Schaerer,Silvio Hemmi,Reinhard Dummer	523
13	Novel MITF targets identified using a two‐step DNA microarray strategy 2008 ·Pigment Cell & Melanoma Research ·Keith S. Hoek,Natalie C. Schlegel,Ossia M. Eichhoff,Daniel Widmer,Christian Praetorius,(unknown),Sigrı́dur Valgeirsdóttir,Kristín Bergsteinsdóttir,Alexander Schepsky,Reinhard Dummer,Eirı́kur Steingrı́msson	193
14	Loss of maspin expression contributes to a more invasive potential in malignant melanoma 2007 ·Pigment Cell Research ·(unknown),Marcus Bettstetter,Peter J. Wild,Keith S. Hoek,Frauke Bataille,Wolfgang Dietmaier,Anja‐Katrin Bosserhoff	36
15	DNA microarray analyses of melanoma gene expression: a decade in the mines 2007 ·Pigment Cell Research ·Keith S. Hoek	64
16	Potassium channel expression profiles in human melanoma cells. 2006 ·Cancer Research ·(unknown),(unknown),Keith S. Hoek,Reinhard Dummer,Mirjana Ziemer,Martin Kaatz,Stefan H. Heinemann,(unknown)	1
17	Mitf regulation of Dia1 controls melanoma proliferation and invasiveness 2006 ·Genes & Development ·Suzanne Carreira,Jane Goodall,Laurence Denat,Mercedes Rodríguez,Paolo Nucíforo,Keith S. Hoek,Alessandro Testori,Lionel Larue,Colin R. Goding	450
18	Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas 2004 ·Cancer Research ·Keith S. Hoek,David L. Rimm,Kenneth R. Williams,Hongyu Zhao,Stephan Ariyan,Lin Ai,Harriet M. Kluger,Aaron J. Berger,Enhao Cheng,E. Sergio Trombetta,Terence Wu,(unknown),Kenichi Yoshikawa,(unknown),Ruth Halaban	371
19	Imiquimod in basal cell carcinoma: how does it work? 2003 ·British Journal of Dermatology ·Reinhard Dummer,Mirjana Urosevic,Werner Kempf,Keith S. Hoek,Jürg Hafner,G. Burg	62
20	Binding of an RNA Trafficking Response Element to Heterogeneous Nuclear Ribonucleoproteins A1 and A2 2000 ·Journal of Biological Chemistry ·Jianguo Shan,Kim Moran‐Jones,Trent P. Munro,Grahame J. Kidd,Donald J. Winzor,Keith S. Hoek,Ross Smith	50

About Keith S. Hoek

Keith S. Hoek is a scholar working on Immunology and Allergy, Cell Biology and Molecular Biology, having authored 40 papers that have together received 4.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (14 papers), Cell Adhesion Molecules Research (9 papers) and Cutaneous Melanoma Detection and Management (6 papers). The work is most often cited by research in Cell Biology (1.2k citations), Immunology and Allergy (340 citations) and Oncology (1.5k citations). Keith S. Hoek has collaborated with scholars based in Switzerland, United States and Australia. Frequent co-authors include Colin R. Goding, Reinhard Dummer, Natalie C. Schlegel, Ossia M. Eichhoff, Silvio Hemmi, Ross Smith, Udo Döbbeling, Nikita Kobert, Leo Schaerer and Lionel Larue. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact